
Study Finds Organ Transplant Recipients Remain Vulnerable to COVID-19 Even After Second Vaccine Dose
The research is a follow-up to a previous study published in March in which the researchers reported that only 17% of participating transplant recipients produced sufficient antibodies after just 1 dose of a 2-dose COVID-19 vaccine regimen.

























